CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 64 enrolled / 64 target
Drug / intervention
Thread embedding acupuncture +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06858137
NCT06858137N/ACompletedHigh Momentum (4.1/mo)Completion was 11mo ago

Efficacy and Safety of Thread Embedding Acupuncture for Rhinitis Allergy: Randomized Controlled Trial

University of Medicine and Pharmacy at Ho Chi Minh City·interventional·Posted Mar 5, 2025·Updated Jun 9, 2026

In Brief

A clinical study evaluating Thread embedding acupuncture and Standal treatment for Rhinitis Allergic. Completed, enrolled 64 participants across 1 site.

Signals

Enrolling ahead of pace

Detailed Summary

Rhinitis allergy is chronic non-communicable disease with a rapid increase in the number of patients since 1990s. Rhinitis allergy is one of the risk factors for various chronic others including asthma, sinusitis, otitis media, as well as some conditions sleep disorders, emotional disorders related. There are numerous pharmacological and non-pharmacological therapies that have been employed in management of these condition. Among them, thread embedding acupuncture (TEA) has been a widely used and established method for various chronic diseases, demonstrating its effectiveness, safety, and convenience. Several studies have shown a significant increase in treatment when combining TEA with pharmacological or other acupuncture therapies. However, there is currently no substantial data on the application of TEA for rhinitis allergy treatment. This study is conducted to assess the efficacy and safety of combining TEA with inhaled corticosteroid (INCS) compared with ICS monotherapy in rhinitis allergy

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesVietnam
Collaborators--

Timeline

N/ACompletedFinished
2026
First PostedMar 5, 2025
Enrollment StartMar 15, 2025
Primary CompletionJul 31, 2025
Study CompletionAug 31, 2025
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 1.3 years ago

Arms & Interventions

Thread embedding acupuncture + fluticasone propionate sprayexperimental

Thread embedding acupuncture (TEA) every two weeks in four weeks (two sessions). Combined with fluticasone propionate spray (INCS) when needed in four weeks and lifestyle changing

Other: Thread embedding acupunctureOther: Standal treatment
fluticasone propionate sprayactive_comparator

Fluticasone propionate when needed in four weeks combined lifestyle changing

Other: Standal treatment

Interventions

Thread embedding acupunctureother

Thread embedding acupuncture is performed every two weeks in four weeks using a single Polydioxaone thread. Needles have a gauge size of 30G, a shaft length of 26mm, folded in half, and are applied to nine acupoints, including Yintang (EX-HN3), Yingxiang (LI20) on both sides of the body. Needles with a gauge size of 29G, a shaft length of 30mm, and a thread length of 50mm, folded in half, are used for three acupoints, which included Hegu (LI4), Zusanli (ST36), Feishu (BL13), on both sides of the body. After the thread being inserted into the body, the needle will be withdrawn immediately.

Standal treatmentother

Inhaled corticosteroid spray - fluticasone propionate patients were permitted to use Fluticasone propionate 1 or 2 sprays (50 mcg/spray) in each nostril once a day as needed in four weeks and participants must change life style attaches including smoke and traffic pollution avoidant, preventing pets going into the bedroom, washing clothes.